CRISPR Therapeutics Q1 2026 Earnings Slight EPS Miss as Clinical Pipeline Progresses ROKU Q1 2026 Earnings Strong EPS Beat Drives Positive Investor Sentiment Estee Lauder EL Q1 2026 Earnings Strong EPS Beat Drives DoubleDigit Stock Surge LNKB Q4 2025 Earnings EPS Misses Estimates by Wide Margin Stock Unchanged Ceragon Networks Q1 2026 Earnings EPS Beats Estimates as Stock Surges RAVE Q3 2024 Earnings EPS of 004 Reported Shares Edge Lower